Are you Dr. Rosebraugh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
17316 Avenleigh Dr
Ashton, MD 20861Phone+1 301-570-0843- Is this information wrong?
Summary
- Dr. Curtis Rosebraugh, MD is a board certified internist in Ashton, Maryland. He is currently licensed to practice medicine in Maryland, District of Columbia, and Texas.
Education & Training
- University of Kansas School of MedicineResidency, Internal Medicine, 1986 - 1989
- University of Kansas School of MedicineClass of 1986
Certifications & Licensure
- MD State Medical License 1998 - 2025
- KS State Medical License 1989 - 2024
- DC State Medical License 1998 - 2020
- TX State Medical License 1994 - 2000
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 81 citationsThe U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.Anthony G. Durmowicz, Robert Lim, Hobart Rogers, Curtis J. Rosebraugh, Badrul A. Chowdhury> ;Annals of the American Thoracic Society. 2018 Jan 1
- 2 citationsDosing of Etelcalcetide and Cinacalcet for Secondary Hyperparathyroidism.Mary T. Thanh Hai, Jean-Marc Guettier, Curtis J. Rosebraugh> ;JAMA. 2017 May 23
- 343 citationsPancreatic safety of incretin-based drugs--FDA and EMA assessment.Amy Egan, Eberhard Blind, Kristina Dunder, Pieter A. de Graeff, B. Timothy Hummer, Todd Bourcier, Curtis Rosebraugh> ;The New England Journal of Medicine. 2014 Feb 26
- Join now to see all
Press Mentions
- FDA Approves New Treatment for People with COPDAugust 1st, 2014
- FDA Approves New Type 2 Diabetes DrugAugust 1st, 2014
- FDA Approves Otezla to Treat Psoriatic ArthritisFebruary 10th, 2016